B01診斷與監測用醫材、C00應用生技

行動基因專注於癌症的精準醫療，依據基因特性評估標靶、免疫、荷爾蒙以及化學治療，將複雜的基因資訊轉化為可實行的癌症治療方案。目前在台灣、新加坡、香港及日本均設有服務據點。行動基因透過尖端技術進行基因檢測，搭配縝密的疾病與藥物分析，提供癌症治療之最佳方針、癌症復發與抗藥性監控、特定癌症風險評估和免疫治療評估。行動基因致力於改寫癌症診斷、治療、監控的既有模式，讓癌症成為一個能被管理的疾病。 ACT Genomics is a leading precision oncology company headquartered in Taiwan with extended footprints in China, Japan, Hong Kong and Singapore. With our certified NGS platform and comprehensive genomic profiling, we help patients find the right treatments. At the same time, we collaborate with bio-pharmaceutical companies to accelerate clinical trials in drug development and CDX development. Our expertise in bioinformatics and medical interpretation enables us to deliver comprehensive and comprehensible medical reports and build cancer genomics database.

個人化精準醫療、臨床癌症基因檢測報告、臨床醫藥資訊分析。 Cutting-edge NGS Service Platform: We provide precise cancer genetic variants detection through minimum tumor samples through our ultra-sensitive NGS Platform for FFPE samples and liquid biopsy. Highest standard Lab with international accreditation: We are recognized and certified by the highest international standard CAP (NGS) accreditation. Our flagship ACTOnco®, the comprehensive genomics panel, that covers 440 genes. Professional Bioinformatics and Biomedical Team: We are strengthened by dozens of bio-informaticians to support customized biomarker analysis. Integrated Comprehensive Cancer Services: We engage from every angle, early-late phase clinical trials, post-marketing drug development, clinician consultation and patient education. Precision Patient Enrollment: We identifies the patients who harbor with rare or specific biomarkers through the clinical services and connect the treating physicians to the sponsors in Taiwan, Hong Kong and Singapore. Asian Genome Database: We integrate genomic databases information with Asia specific genome profiling